Dianthus Therapeutics DNTH Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Dianthus Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dianthus Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dianthus Therapeutics's book value per share?
- Dianthus Therapeutics (DNTH) reported book value per share of $25.01 in Q1 2026.
- How has Dianthus Therapeutics's book value per share changed year-over-year?
- Dianthus Therapeutics's book value per share increased by 172.4% year-over-year, from $9.18 to $25.01.
- What is the long-term trend for Dianthus Therapeutics's book value per share?
- Over 4 years (2020 to 2024), Dianthus Therapeutics's book value per share has grown at a 34.1% compound annual growth rate (CAGR), from $3.28 to $10.58.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.